CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NVO — Novo Nordisk A S
CIK 884546
SAN FRANCISCO, CA
Position in NVO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,865,181
+$15,853,730 QoQ
Shares Held
622,970
+63.4% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 1,348 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $34,394,076,697 across 15 Drug Manufacturers - General names. NVO ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,001,955 | $7,198,925,485 | |
| 2 | MRK |
Merck & Co., Inc.
|
54,365,289 | $6,985,939,635 | |
| 3 | AMGN |
Amgen Inc
|
15,034,038 | $5,444,125,839 | |
| 4 | JNJ |
Johnson & Johnson
|
19,126,165 | $4,857,472,124 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,595,177 | $3,894,834,098 | |
| 6 | ABBV |
AbbVie Inc.
|
12,914,230 | $3,249,736,836 | |
| 7 | PFE |
Pfizer Inc
|
52,548,228 | $1,265,361,329 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,155,281 | $1,030,338,200 |
All Filings in NVO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,865,181 | 622,970 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $14,011,451 | 381,264 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $20,453,658 | 401,998 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,538,680 | 370,133 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $21,715,555 | 314,627 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $18,140,713 | 261,243 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $19,433,122 | 225,914 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $24,359,697 | 204,583 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $25,064,430 | 175,595 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $16,444,059 | 128,069 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $9,780,576 | 94,544 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $6,227,298 | 68,477 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,204,072 | 19,799 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,843,955 | 11,587 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $903,123 | 6,673 | Shares | Sole | 2023-02-13 | |
| 2021-06-30 | $3,725,000 | 44,467 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $7,335,970 | 108,810 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,232,271 | 175,122 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,060,684 | 116,098 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,263,240 | 19,292 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $3,656,247 | 60,735 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||